Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP621893.RAwRkY7WWsp8TEr6e8YrIkxIISsUhAIOPjijMpl_8dl9I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP621893.RAwRkY7WWsp8TEr6e8YrIkxIISsUhAIOPjijMpl_8dl9I130_assertion type Assertion NP621893.RAwRkY7WWsp8TEr6e8YrIkxIISsUhAIOPjijMpl_8dl9I130_head.
- NP621893.RAwRkY7WWsp8TEr6e8YrIkxIISsUhAIOPjijMpl_8dl9I130_assertion wasGeneratedBy ECO_0000203 NP621893.RAwRkY7WWsp8TEr6e8YrIkxIISsUhAIOPjijMpl_8dl9I130_provenance.
- NP621893.RAwRkY7WWsp8TEr6e8YrIkxIISsUhAIOPjijMpl_8dl9I130_assertion wasDerivedFrom befree-20150227 NP621893.RAwRkY7WWsp8TEr6e8YrIkxIISsUhAIOPjijMpl_8dl9I130_provenance.
- NP621893.RAwRkY7WWsp8TEr6e8YrIkxIISsUhAIOPjijMpl_8dl9I130_assertion SIO_000772 24011934 NP621893.RAwRkY7WWsp8TEr6e8YrIkxIISsUhAIOPjijMpl_8dl9I130_provenance.
- NP621893.RAwRkY7WWsp8TEr6e8YrIkxIISsUhAIOPjijMpl_8dl9I130_assertion evidence source_evidence_literature NP621893.RAwRkY7WWsp8TEr6e8YrIkxIISsUhAIOPjijMpl_8dl9I130_provenance.
- NP621893.RAwRkY7WWsp8TEr6e8YrIkxIISsUhAIOPjijMpl_8dl9I130_assertion description "[These studies identify dual targeted inhibitors of PI3K/mTOR in combination with inhibitors of RAS/ERK signalling as a potentially effective new approach to treating ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621893.RAwRkY7WWsp8TEr6e8YrIkxIISsUhAIOPjijMpl_8dl9I130_provenance.